跳转至内容
Merck
CN
  • A GBM-like V-ATPase signature directs cell-cell tumor signaling and reprogramming via large oncosomes.

A GBM-like V-ATPase signature directs cell-cell tumor signaling and reprogramming via large oncosomes.

EBioMedicine (2019-02-10)
Irene Bertolini, Andrea Terrasi, Cristina Martelli, Gabriella Gaudioso, Andrea Di Cristofori, Alessandra Maria Storaci, Miriam Formica, Paola Braidotti, Katia Todoerti, Stefano Ferrero, Manuela Caroli, Luisa Ottobrini, Thomas Vaccari, Valentina Vaira
摘要

The V-ATPase proton pump controls acidification of intra and extra-cellular milieu in both physiological and pathological conditions. We previously showed that some V-ATPase subunits are enriched in glioma stem cells and in patients with poor survival. In this study, we investigated how expression of a GBM-like V-ATPase pump influences the non-neoplastic brain microenvironment. Large oncosome (LO) vesicles were isolated from primary glioblastoma (GBM) neurospheres, or from patient sera, and co-cultured with primary neoplastic or non-neoplastic brain cells. LO transcript and protein contents were analyzed by qPCR, immunoblotting and immunogold staining. Activation of pathways in recipient cells was determined at gene and protein expression levels. V-ATPase activity was impaired by Bafilomycin A1 or gene silencing. GBM neurospheres influence their non-neoplastic microenvironment by delivering the V-ATPase subunit V1G1 and the homeobox genes HOXA7, HOXA10, and POU3F2 to recipient cells via LO. LOs reprogram recipient cells to proliferate, grow as spheres and to migrate. Moreover, LOs are particularly abundant in the circulation of GBM patients with short survival time. Finally, impairment of V-ATPase reduces LOs activity. We identified a novel mechanism adopted by glioma stem cells to promote disease progression via LO-mediated reprogramming of their microenvironment. Our data provide preliminary evidence for future development of LO-based liquid biopsies and suggest a novel potential strategy to contrast glioma progression. FUND: This work was supported by Fondazione Cariplo (2014-1148 to VV) and by the Italian Minister of Health-Ricerca Corrente program 2017 (to SF).

材料
产品编号
品牌
产品描述

Sigma-Aldrich
黏着斑蛋白单克隆抗体 小鼠抗, clone hVIN-1, ascites fluid
Sigma-Aldrich
抗胶质纤维酸性蛋白 兔抗, IgG fraction of antiserum, buffered aqueous solution
Sigma-Aldrich
单克隆抗-少突胶质细胞标记物O4 小鼠抗, clone O4, purified immunoglobulin, lyophilized powder
Sigma-Aldrich
抗-β-微管蛋白III 兔抗, ~1 mg/mL, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Anti-OLIG2 (AB1) antibody produced in rabbit, affinity isolated antibody